Trending: CVS to Pay $5 Billion to Settle Opioid Lawsuits
02 Novembro 2022 - 11:50AM
Dow Jones News
10:20 ET -- CVS Health Corp. is the most talked about company in
the U.S. across all news items in the last 12 hours, according to
Factiva data. The U.S. drugstore chain and rival Walgreens Boots
Alliance Inc. agreed to pay more than $10 billion to resolve
opioid-crisis lawsuit brought by states, cities and other
governments, reaching a framework to settle suits that blamed
pharmacies for helping fuel the nation's opioid epidemic. Under the
proposed deal, CVS would pay $4.9 billion to states and
municipalities and $130 million to Native American tribes over the
next 10 years starting in 2023, though the company said the
agreement isn't an admission of guilt and that it would continue to
defend against any litigation that the settlement doesn't resolve.
CVS shares are up 4.2% at $98.56. Dow Jones & Co. owns Factiva.
(robb.stewart@wsj.com)
(END) Dow Jones Newswires
November 02, 2022 10:35 ET (14:35 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Dez 2022 até Jan 2023
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Jan 2022 até Jan 2023